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Abstract
Introduction
Chronic obstructive pulmonary disease (COPD) is associated with
cognitive impairment, but consequences of this association on a
person’s functional limitations are unclear. We examined the asso-
ciation between COPD and increased confusion and memory loss
(ICML) and functional limitations among adults with COPD.
Methods
We studied adults aged 45 years or older in 21 states who particip-
ated in the 2011 Behavioral Risk Factor Surveillance System (n =
102,739). Presence of COPD was based on self-reported physi-
cian diagnosis. ICML was based on self-report that confusion or
memory loss occurred more often or worsened during the prior
year.  ICML-associated  difficulties  were  defined  as  giving  up
household chores and former activities, decreased ability to work
or  engage in  social  activities,  or  needing help  from family  or
friends during the prior year due to ICML. General limitations
were defined as needing special equipment as a result of a health
condition, having had activity limitations for 2 weeks or more in
the prior month, or being unable to work. Multivariable models
were adjusted for demographics, health behaviors or conditions,
and frequent mental distress.
Results
COPD was reported by 9.3% of adults. ICML was greater among
those with COPD than among those without COPD (25.8% vs
11%; adjusted prevalence ratio [aPR], 1.48; 95% confidence inter-
val  [CI],  1.32%–1.66%).  People  with  COPD,  either  with  or
without ICML, were more likely than those without COPD to re-
port  general  functional  limitations.  Among  people  reporting
ICML, those with COPD were more likely to report interference
with work or  social  activities  than those without  COPD (aPR,
1.17; 95% CI, 1.01%–1.36%).
Conclusion
Functional limitations were greater among those with COPD than
among those without, and ICML may further affect these limita-
tions. Results from our study can inform future studies of self-
management and functional limitations for people with COPD.
Introduction
Cognitive impairment among people with chronic obstructive pul-
monary disease (COPD) has been observed in community popula-
tions (1–4). Details of the association between cognitive impair-
ment  and COPD are emerging;  however,  its  consequences for
people living with COPD are unclear. A systematic review con-
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cluded that future research on the effects of cognitive impairment
on people living with COPD should include its impact on daily
living and self-care (5). At least 1 study observed that adults with
COPD had more functional limitations in activities of daily living
and self-care than adults without COPD (6). However, the impact
of cognitive impairment on activities of daily living and self-care
among adults with COPD has received little attention and requires
assessment.
Cognitive health issues may range from mild impairment to some
type of  dementia,  including Alzheimer’s  disease.  People  with
COPD may have overall cognitive impairment or impairment in
specific cognitive domains that affect information processing, at-
tention, concentration, memory, executive functioning, and self-
control (5). Memory problems are a common early sign of cognit-
ive impairment (7), which may begin many years before it is clin-
ically diagnosed. Therefore, self-reported memory problems have
generated interest as a marker of cognitive decline. People who
complain about memory loss appear to be at greater risk of devel-
oping mild cognitive impairment or dementia (8–11). However,
some studies suggest that complaints about memory loss may be
related to psychological distress and not necessarily to cognitive
impairment (8,10,12).
Cognitive impairment in conjunction with COPD may be related
to hypoxia  or  hypercapnia  (5,13)  or  to  acute  exacerbations  of
COPD (14).  In  addition,  cigarette  smoking,  a  major  cause  of
COPD, is associated with decreased cognitive function and in-
creased cognitive decline (4,15–17); the 2011 Behavioral Risk
Factor Surveillance System (BRFSS) showed that almost 40% of
adults  with  COPD that  year  were  smokers  (18).  Furthermore,
COPD  frequently  co-occurs  with  other  chronic  conditions
(19–21), many of which also can involve cognitive impairment,
such as heart and vascular diseases (22,23), diabetes (24), and
stroke (23).
The  2011 BRFSS collected  self-reported  information  on  both
physician-diagnosed COPD (16) and on confusion or memory loss
(25,26) among participants in 21 states. This large sample of more
than 100,000 respondents is probably reflective of the heterogen-
eous population that physicians encounter in general practice. We
conducted cross-sectional analyses to examine 1) the association
between COPD and increased confusion or memory loss (ICML),
adjusting for potential confounders, and 2) differences in function-
al limitations by ICML and COPD status, Results of our analyses
can inform  self-management and community-based programs
about the cognitive and functional needs of people with COPD.
Methods
BRFSS is a state-based telephone survey of adults aged 18 years
or older, which is conducted by state health departments with as-
sistance from the  Centers  for  Disease  Control  and Prevention
(CDC). BRFSS samples people with landline and people with cel-
lular telephones to obtain representative samples of the noninstitu-
tionalized adult population. Data are weighted to state population
estimates using iterative proportional fitting or “raking.” Details
on BRFSS design, methodology, sampling procedures, reliability,
and validity are available (www.cdc.gov/brfss). The survey in-
cludes core questions asked in all states and optional modules on
specific topics, which states select based on their programmatic
needs. Optional modules may include the full state sample or split
samples  to  allow states  to  obtain  information  on  more  public
health topics of interest to the state programs. In 2011, COPD
status was part of the core BRFSS survey. An optional module
asked 138,874 people in 21 states about increased confusion or
memory loss (ICML) and associated functional difficulties. The 21
states were Arkansas, California, Florida, Hawaii, Illinois, Iowa,
Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New
York,  North  Carolina,  Oklahoma,  South  Carolina,  Tennessee,
Texas, Utah, Washington, West Virginia, and Wisconsin. The me-
dian response rate was 53.4% using response rate standards of the
American  Association  of  Public  Opinion  Research  (http://
www.aapor.org/AAPORKentico/Communications/AAPOR-Journ-
als/Standard-Definitions.aspx). BRFSS procedures were reviewed
by the CDC Human Research Protections Office and determined
to be exempt research. All analyses were performed using data
from the BRFSS public use files.
We determined COPD status from responses to the BRFSS ques-
tion, “Have you ever been told by a doctor or health professional
that  you have COPD, emphysema, or  chronic bronchitis?” In-
creased confusion or memory loss was determined from responses
to the question, “During the past 12 months,  have you experi-
enced confusion or memory loss that is happening more often or is
getting worse?” We examined both ICML-associated functional
difficulties (questions asked only of those reporting ICML) and
general physical limitations (questions asked of all adults regard-
less of ICML status).  BRFSS assessed ICML-associated diffi-
culties by asking respondents who reported ICML how often in
the previous year 1) they gave up household activities or chores
they formerly engaged in because of ICML or 2) how often in the
previous year ICML interfered with their ability to work, volun-
teer, or engage in social activities. We grouped responses for these
2 questions as “always,” “usually,” or “sometimes” versus “rarely”
or “never.” Respondents also noted in which areas they needed
most help because of ICML (safety,  transportation,  household
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activities, personal care, some other area, or no areas). We determ-
ined whether a respondent needed help in any category of help
compared with needing no help. Additionally, respondents noted if
they received help from family or friends in the previous 30 days
because  of  ICML;  we  categorized  responses  as  “always,”
“usually,” or “sometimes” versus “rarely” or “never.”). We ex-
amined 3 general areas of physical or mental limitations. First we
determined whether a respondent needed special equipment be-
cause of a health condition. Second we determined whether a re-
spondent had 2 or more weeks of limited physical activity in the
prior month; such determination was based on responses to ques-
tions asking whether respondents had any days when physical
health was not good, had days when mental health was not good,
and the number of days that poor physical or mental health kept
them from their usual activities (eg, self-care, work, recreation).
Third, we determined respondents’ employment status from re-
ports of “unable to work.”  Specific health reasons for these gener-
al limitations were not ascertained.
Demographic variables used in our analyses were age, sex, race/
ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, all
others), education (less than high school, high school or equival-
ent, more than high school), number of adults in the household (1,
≥2), health care insurance coverage, and state of residence. Health
behaviors used were smoking status, obesity status, and physical
inactivity. Current smokers were those who smoked at least 100
cigarettes in their lifetime and currently smoked every day or some
days. Former smokers were those who smoked at least 100 cigar-
ettes in their lifetime but did not currently smoke. Never smokers
were those who had never smoked at least 100 cigarettes in their
lifetime. Body mass index (BMI), calculated from self-reported
height and weight, was categorized as underweight (BMI <18.5
kg/m2), normal weight (BMI 18.5–24.9 kg/m2), overweight (BMI
25.0–29.9 kg/m2), and obese (BMI ≥30 kg/m2). Respondents were
asked if they engaged in any leisure time physical activity in the
prior month (yes/no). Chronic disease risk factors and conditions
were determined by asking, “Have you ever been told by a doctor
or health professional that you have . . . high blood pressure, high
cholesterol, heart disease (myocardial infarction or coronary heart
disease), stroke, diabetes, or current asthma?”  Finally, frequent
mental distress (defined as psychological distress experienced for
14 or more days in the prior month) was assessed with the ques-
tion,  “Now thinking about your mental  health,  which includes
stress, depression, and problems with emotions, for how many
days during the past 30 days was your mental health not good?”
(27). For our purposes, frequent mental distress captures more
than clinically diagnosed depression and reflects a wider range of
psychological distress.
We combined data for the 21 states and restricted analyses to re-
spondents aged 45 years or older who were not missing data for
COPD  status  (N  =  105,332:  10,476  with  COPD  and  94,856
without COPD), because the sample sizes for those with COPD
younger than 45 were too small for reliable comparisons. We used
appropriate population weights for full and split samples for the
ICML module. SAS (SAS Institute) and SAS-callable SUDAAN
(Research Triangle Institute) were used to account for the com-
plex sampling design and for variance estimation. We first ex-
amined differences in demographic and health characteristics by
COPD status. We then examined differences in ICML by COPD
status. Finally, we compared functional limitations by ICML and
COPD status. Adjusted prevalence ratios were calculated by using
3 models. Model 1 was adjusted for sex, race/ethnicity, education,
number of adults in the household, health care coverage, state of
residence, and age (as a continuous variable). Model 2 was adjus-
ted for model 1 covariables plus health behaviors and risk factors
(smoking, obesity status, physical inactivity, high blood pressure,
high cholesterol) and presence of at least 1 other chronic condi-
tion (heart disease, stroke, diabetes, current asthma). Model 3 was
adjusted for models 1 and 2 plus frequent mental distress. For de-
scriptive analyses, sample sizes were allowed to vary. Multivari-
able analyses were restricted to respondents with no missing data
for all covariables so we could compare prevalence ratios across
models for the relevant outcome. Significance was determined as
P < .05. We checked relative standard errors to assess stability of
estimates.
Results
Among people aged 45 years or older in the 21 states studied, the
weighted percentage with COPD was 9.3% (95% confidence inter-
val [CI],  8.9%–9.7%). Compared with those without COPD, a
higher percentage of people with COPD were aged 65 to 84 years,
were women, were white,  had a high school education or less,
were current smokers, were physically inactive, were obese, had
other chronic disease risk factors and conditions, and had frequent
mental distress (Table 1). People with COPD were less likely to
report Hispanic ethnicity.
Overall, 12.4% (95% CI, 11.9%–12.9%) of people reported ICML
during the previous year, and ICML was greater among people
with  COPD  (25.8%;  95%  CI,   23.9-27.8)  than  among  those
without COPD (11.0%; 95% CI, 10.5–11.6). Overall, the percent-
age reporting ICML was higher  among those reporting stroke
(29.7%; 95% CI, 26.9–32.7) than it was among those with COPD
(25.8%), but was lower for those reporting current asthma (22.3%;
95% CI, 20.1–24.6), heart disease (21.4%; 95% CI, 19.7–23.2) or
diabetes (17.2%; 95% CI, 15.9–18.6).
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Within each demographic, health behavior, or health condition
group, the percentage with ICML was greater among those with
COPD than without COPD (Table 2).  The only exception was
among underweight people, for whom the percentage of ICML did
not differ by COPD status because of large confidence intervals.
Interestingly, among those with COPD, the percentage with ICML
declined with age, whereas ICML was slightly higher among those
in the two oldest age groups of those without COPD. Among both
those with and those without COPD, prevalence of ICML tended
to be higher among Hispanics than whites, lower with more at-
tained  education,  higher  among  current  smokers  than  among
former or never smokers, and higher among those with chronic
conditions or frequent mental distress than among those without.
Prevalence  of  ICML increased  with  body weight  both  among
people with COPD and among those without except among under-
weight people without COPD.
We used logistic regression to further examine the inverse associ-
ation of age and ICML among people with COPD. When age was
examined as a continuous variable, the inverse association of age
with ICML among people with COPD was   significant (odds ra-
tio [OR]: 0.98; 95% CI: 0.97–0.99, P < .001). However, this asso-
ciation was not significant after we adjusted for frequent mental
distress (OR: 0.99; 95% CI: 0.98–1.00, P = .19). Similar patterns
were observed when we examined age grouped into 5-year inter-
vals.
In multivariable analyses (N = 82,013 for all models; 7,888 people
with  COPD and  74,125  people  without  COPD)  adjusting  for
demographics,  the  prevalence  ratio  of  ICML for  people  with
COPD versus those without COPD was 2.25 (95% CI, 2.03–2.49).
When further adjusted for health risk behaviors and conditions, the
prevalence ratio was 1.69 (95% CI, 1.51–1.89). After additional
adjustment for frequent mental distress, the prevalence ratio was
1.48 (95% CI, 1.32–1.66).
The Figure shows 1) general limitations among people with and
people without ICML and 2) ICML-associated limitations among
those  reporting  ICML,  by  COPD  status.  General  limitations
among those either with ICML or without ICML were greater
among those with COPD than without the condition (P < .05).
People with both ICML and COPD were more likely than those
with ICML but without COPD to report having ICML-associated
limitations or having received assistance because of ICML. ICML-
associated limitations among those with COPD ranged from al-
most one-third reporting having received assistance from family or
friends because of ICML to almost two-thirds reporting needing
assistance in at least 1 of 5 domains (safety, transportation, house-
hold activities, personal care, or some other domain).
Figure.  Functional  limitations  among  persons  with  or  without  reported
increased confusion or memory loss (ICML), by chronic obstructive pulmonary
COPD  status,  adults  aged  45  years  and  older  in  21  states  (Arkansas,
California,  Florida,  Hawaii,  Illinois,  Iowa,  Louisiana,  Maryland,  Michigan,
Nebraska,  New Hampshire,  New York,  North  Carolina,  Oklahoma,  South
Carolina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin),
2011 Behavioral Risk Factor Surveillance System. Domains where help was
needed are safety, transportation, household activities, personal care, and
other.  Abbreviations:  CI,  confidence  interval;  COPD,  chronic  obstructive
pulmonary disease; —, not applicable.
 
When adjusted for all covariables (Table 3), people with COPD
remained more likely than those without COPD to report each
general activity limitation. This was true for both those with and
those without ICML. For ICML-related limitations, after full ad-
justment, people with ICML and COPD were more likely than
those with ICML but no COPD to report interference with work,
volunteering, or social activities (aPR,1.17; 95% CI, 1.01–1.36)
because of ICML.
Discussion
Associations between COPD and cognitive impairment are com-
plex and may be due to numerous factors, including hypoxia or
hypercapnia, combined effects of co-occurring chronic conditions
with COPD, or effects of tobacco smoking. Although we did not
have information on severity of either COPD or ICML, our res-
ults in a large sample of community dwelling adults aged 45 years
or older suggested that people with COPD were more likely than
those  without  COPD to  report  confusion or  memory loss  that
worsened over the previous year, even after controlling for numer-
PREVENTING CHRONIC DISEASE VOLUME 13, E02
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY     JANUARY 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
4       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/15_0428.htm
ous potential confounders, such as demographic variables, co-oc-
curring health risk factors and conditions, and frequent mental dis-
tress. General limitations were greater among those with COPD
than those without regardless of ICML status, and the percentages
reporting ICML-associated difficulties were substantial  in this
community-dwelling sample.
Subjective cognitive decline has received considerable attention in
the literature as interest has grown in identifying early markers of
cognitive decline. Previous studies suggest that subjective memory
complaint is associated with psychological distress, yet is also in-
dependently related to development of dementia (8–11). We ob-
served a  higher  prevalence of  frequent  mental  distress  among
people with COPD than among those without, and associations
between COPD and ICML were attenuated but remained signific-
ant after adjustment for frequent mental distress, suggesting that
both ICML and psychological distress are associated with COPD.
Both psychological distress and cognitive functioning can affect
treatment, self-management, and quality of life for people with
COPD; therefore, consideration of both factors may be important.
A review of a growing body of research suggests that specific be-
havioral and psychological aspects of dementia might be amen-
able  to  intervention (28).  Psychological  factors  involved with
COPD may be addressed by pulmonary rehabilitation, although
the  benefits  of  pulmonary  rehabilitation  for  cognitive  decline
among people with COPD remains unclear (29).
Our  observation  of  an  inverse  association  of  ICML with  age
among people with COPD was at least partly explained by fre-
quent mental distress, confirming potential confounding between
psychological distress and ICML (20–24). Several other reasons
should also be considered for results based on surveys of the gen-
eral population. First, it is possible that recognition of memory
problems is greater when symptoms and their effects on function-
al status are first noticed, especially if attributed to another condi-
tion. Additionally, our sample consisted of community-dwelling
adults; adults with COPD or ICML who reside in institutional set-
tings (who may have more severe COPD or ICML) are not repres-
ented. In a study that included 27,106 people with COPD in US
nursing homes from 2009 through 2010, 61.9% had short-term
memory problems and 43.3% had moderately  or  severely  im-
paired cognitive skills (30). Finally, although the association of
ICML and age by COPD status may be confounded by psycholo-
gical distress, the inverse association of ICML with age among
people with COPD may signify a healthy survivor effect.
Several limitations should be noted (25,26). First, these analyses
relied on self-report of both COPD and ICML. How cognitive
impairment influences self-reports is unclear. For example, re-
spondents need to be able to answer questions over the telephone
for the BRFSS, and it is not known how ICML might affect re-
sponses or ability to report functional limitations. BRFSS ques-
tions were cognitively tested but were not validated against a clin-
ical population or measurement for either condition, although the
COPD question is structured as in other health surveys. Self-repor-
ted information is also subject to recall and social desirability bi-
ases. Additionally, although we had a large sample, these results
were based on adults in 21 states, limiting generalizability. Finally,
analyses were cross-sectional and causality cannot be inferred.
Furthermore, although we controlled for numerous chronic condi-
tions, we were not able to control for neurological conditions oth-
er than stroke. However, our results support prior observations that
those with COPD have more self-reported memory complaints.
Also, because cognitive problems may begin many years before
other symptoms appear or a clinical diagnosis is made, self-re-
ports or those of proxy respondents are important to consider.
Although further research is needed, our results can inform treat-
ment and self-management of people living with COPD. Because
even middle-aged adults (age 45–64 y) with COPD were more
likely  to  report  ICML than  were  middle-aged  people  without
COPD, health care providers should consider assessing the cognit-
ive functioning of their patients with COPD because impairments
may affect treatment and management outcomes. Furthermore, al-
though the associations between ICML and COPD status was at-
tenuated with adjustment for frequent mental distress, these asso-
ciations remained, suggesting that both cognitive impairment and
psychological distress should be assessed and monitored for ef-
fective treatment and self-management. Finally, specific function-
al limitations that may be of particular concern to people with
COPD can be addressed.
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Tables
Table 1. Demographic and Health Characteristics of Adults Aged 45 Years or Older in 21 Statesa, by COPD Status, 2011 Behavior-
al Risk Factor Surveillance System
Characteristic
With COPD (N = 10,476) Without COPD (N = 94,856)
n % (95% CI)b n % (95% CI)b
Age, y
45–54 1,670 25.3 (23.2–27.6) 22,522 37.8 (37.0–38.5)
55–64 3,000 29.7 (27.7–31.8) 28,583 29.2 (28.6–29.9)
65–75 3,173 24.7 (22.9–26.7) 23,485 17.7 (17.2–18.2)
75–84 2,116 16.5 (15.3–17.9) 15,335 11.8 (11.4–12.2)
≥85 517 3.7 (3.1–4.3) 4,931 3.4 (3.2–3.6)
Women 7,043 59.2 (56.8–61.5) 59,021 52.5 (51.7–53.2)
Race/ ethnicity
White non-Hispanic 8,485 74.8 (72.4–77.1) 75,095 69.2 (68.4–69.9)
Black non-Hispanic 901 9.5 (8.1–11.0) 8,985 10.2 (9.8–10.7)
Hispanic 260 7.7 (6.3–9.4) 3,683 12.8 (12.1–13.5)
Other 830 8.0 (6.5–9.8) 7,093 7.8 (7.3–8.3)
Education
<High school 1,913 25.6 (23.4–27.9) 8,987 16.2 (15.6–17.0)
High school or equivalent 3,863 32.1 (30.2–34.1) 29,533 27.7 (27.1–28.4)
>High school 4,675 42.2 (40.1–44.4) 56,032 56.0 (55.3–56.8)
Only adult in household 5,004 32.3 (30.5–34.2) 35,047 23.2 (22.7–23.8)
Have health insurance 9,534 89.1 (87.4–90.6) 86,717 88.2 (87.6–88.8)
Smoking status
Never smoker 2,435 21.5 (19.9–23.3) 51,046 52.6 (51.9–53.4)
Former smoker 4,693 44.9 (42.6–47.2) 31,392 32.7 (32.0–33.4)
Current smoker 3,311 33.6 (31.5–35.7) 11,937 14.6 (14.1–15.2)
Physically inactive 4663 45.0 (42.7–47.3) 25,674 27.6 (26.9–28.3)
Body mass index (kg/m2)
Underweight (<18.5) 360 3.2 (2.6–4.0) 1,349 1.3 (1.2–1.5)
Normal weight (18.5–24.9) 2,865 27.1 (25.0–29.2) 29,450 30.6 (29.9–31.3)
Overweight (25.0–29.9) 3,181 31.7 (29.7–33.8) 34,263 38.0 (37.2–38.7)
Obese (≥30.0) 3,708 38.0 (35.7–40.3) 25,755 30.0 (29.3–30.8)
Other chronic disease risk factors
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Percentages are weighted to state population estimates. Totals may vary because of missing responses.
c Heart disease (heart attack, coronary heart disease), stroke, diabetes, current asthma.
(continued on next page)
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(continued)
Table 1. Demographic and Health Characteristics of Adults Aged 45 Years or Older in 21 Statesa, by COPD Status, 2011 Behavior-
al Risk Factor Surveillance System
Characteristic
With COPD (N = 10,476) Without COPD (N = 94,856)
n % (95% CI)b n % (95% CI)b
High blood pressure 6,895 65.8 (63.6–67.8) 47,242 46.8 (46.0–47.5)
High cholesterol 6,135 65.8 (63.7–67.8) 43,488 48.6 (47.9–49.4)
Chronic conditions
Heart disease 3,018 28.0 (26.0–30.0) 10,163 9.8 (9.4–10.3)
Stroke 1,291 11.1 (9.9–12.5) 4,774 4.3 (4.0–4.5)
Diabetes 2,681 25.5 (23.6–27.6) 14,980 15.9 (15.4–16.5)
Current asthma 3,600 36.7 (34.5–38.9) 5,242 5.9 (5.5–6.2)
Any chronic conditionc 6,709 64.5 (62.3–66.6) 27,813 28.2 (27.5–28.9)
Frequent mental distress 2,426 26.9 (24.8–29.1) 8,254 10.5 (10.0–11.1)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Percentages are weighted to state population estimates. Totals may vary because of missing responses.
c Heart disease (heart attack, coronary heart disease), stroke, diabetes, current asthma.
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Table 2. Percentage of Adults Aged 45 Years or Older Reporting ICML, by Demographic and Health Characteristics, Among People
With and People Without COPD, 21 Statesa, 2011 Behavioral Risk Factor Surveillance System
Characteristic
With COPD Without COPD
N % (95% CI)b N % (95% CI)b
Total 9,512 25.8 (23.9-27.8) 87,352 11.0 (10.5–11.6)
Age, y
45–54 1,510 32.5 (27.7–37.8) 20,929 10.7 (9.7–11.8)
55–64 2,762 27.0 (23.5–30.9) 26,662 10.5 (9.7–11.5)
65–75 2,894 21.4 (18.2–25.0) 21,662 10.5 (9.6–11.4)
75–84 1,890 20.7 (17.6–24.2) 13,796 13.1 (11.9–14.4)
≥85 456 23.2 (17.2–30.4) 4,303 14.4 (12.4–16.7)
Sex
Male 3,104 26.0 (22.6–29.7) 32,984 10.9 (10.1–11.8)
Female 6,408 25.7 (23.4–28.0) 54,368 11.1 (10.4–11.8)
Race/ethnicity
White non-Hispanic 7,755 25.0 (23.0–27.1) 69,785 10.2 (9.7–10.7)
Black non-Hispanic 784 23.7 (17.4–31.5) 7,946 11.2 (9.6–13.1)
Hispanic 234 36.1 (26.3–47.3) 3,213 14.0 (11.9–16.3)
Other 739 26.4 (18.1–36.7) 6,408 13.6 (10.8–17.2)
Education
<High school 1,689 28.9 (24.5–33.7) 7,798 16.7 (14.7–18.9)
High school or equivalent 3,472 24.8 (21.7–28.3) 26,858 11.5 (10.6–12.5)
>High school 4,336 25.0 (22.2–28.0) 52,531 9.3 (8.7–9.8)
Number of adults in household
1 4,530 28.8 (26.0–31.8) 32,034 12.3 (11.6–13.1)
2 or more 4,730 24.4 (21.9–27.1) 53,346 10.6 (10.0–11.3)
Have health insurance
No 836 31.4 (24.1–39.8) 7,182 12.8 (11.0–14.7)
Yes 8,663 25.1 (23.1–27.2) 80,024 10.8 (10.3–11.4)
Smoking status
Never smoker 2,213 24.3 (20.5–28.6) 47,077 9.2 (8.5–9.9)
Former smoker 4,256 22.3 (19.8–25.1) 28,947 12.2 (11.3–13.1)
Current smoker 3,016 31.5 (27.8–35.4) 10,913 15.2 (13.6–17.0)
Physical activity status
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Percentages are weighted to state population estimates. Totals may vary because of missing responses.
c Relative standard error is 20% to 30%. Estimate should be used with caution.
d Any chronic health condition: heart disease (heart attack, coronary heart disease), stroke, diabetes, current asthma.
(continued on next page)
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Table 2. Percentage of Adults Aged 45 Years or Older Reporting ICML, by Demographic and Health Characteristics, Among People
With and People Without COPD, 21 Statesa, 2011 Behavioral Risk Factor Surveillance System
Characteristic
With COPD Without COPD
N % (95% CI)b N % (95% CI)b
Any physical activity 5,087 24.7 (22.1–27.6) 62,759 9.7 (9.1–10.3)
No physical activity 4,401 27.1 (24.3–30.0) 24,454 14.6 (13.5–15.7)
Body mass index (kg/m2)
Underweight (<18.5) 314 21.9c (12.2–36.1) 1,224 17.1 (11.1–25.4)
Normal weight (18.5-24.9) 2,611 23.6 (20.3–27.3) 27,199 9.9 (9.1–10.8)
Overweight (25.0-29.9) 2,896 25.9 (22.4–29.7) 31,727 10.2 (9.3–11.2)
Obese (≥30.0) 3,387 28.2 (24.9–31.7) 23,927 13.2 (12.2–14.3)
High blood pressure
No 3,268 22.6 (19.7–25.9) 43,915 9.1 (8.4–9.8)
Yes 6,223 27.5 (25.1–30.1) 43,221 13.2 (12.5–14.0)
High cholesterol
No 3,258 21.4 (18.4–24.6) 40,959 8.5 (7.8–9.2)
Yes 5,593 27.9 (25.3–30.7) 40,211 13.3 (12.5–14.1)
Heart disease
No 6,759 23.3 (21.2–25.6) 77,068 10.2 (9.7–10.8)
Yes 2,728 32.3 (28.3–36.5) 9,215 18.4 (16.5–20.4)
Stroke
No 8,306 23.9 (21.9–26.1) 82,854 10.3 (9.7–10.8)
Yes 1,144 40.1 (34.6–45.8) 4,264 27.1 (23.8–30.6)
Diabetes
No 7,113 24.7 (22.5–27.0) 73,568 10.3 (9.7–10.9)
Yes 2,383 29.2 (25.2–33.5) 13,665 15.1 (13.8–16.5)
Current asthma
No 6,084 23.7 (21.4–26.2) 82,192 10.5 (10.0–11.1)
Yes 3,256 28.5 (25.2–32.1) 4,795 18.3 (15.4–21.6)
Any chronic health conditiond
No 3,460 21.1 (18.3–24.2) 62,033 9.1 (8.6–9.8)
Yes 6,052 28.4 (25.9–31.1) 25,319 15.8 (14.8–16.9)
Frequent mental distress
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Percentages are weighted to state population estimates. Totals may vary because of missing responses.
c Relative standard error is 20% to 30%. Estimate should be used with caution.
d Any chronic health condition: heart disease (heart attack, coronary heart disease), stroke, diabetes, current asthma.
(continued on next page)
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Table 2. Percentage of Adults Aged 45 Years or Older Reporting ICML, by Demographic and Health Characteristics, Among People
With and People Without COPD, 21 Statesa, 2011 Behavioral Risk Factor Surveillance System
Characteristic
With COPD Without COPD
N % (95% CI)b N % (95% CI)b
No 7,077 18.8 (16.9–20.9) 78,366 8.4 (8.0–8.9)
Yes 2,185 44.1 (39.4–48.9) 7,515 33.2 (30.5–36.0)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Percentages are weighted to state population estimates. Totals may vary because of missing responses.
c Relative standard error is 20% to 30%. Estimate should be used with caution.
d Any chronic health condition: heart disease (heart attack, coronary heart disease), stroke, diabetes, current asthma.
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Table 3. Multivariable Adjusted Associations of Functional Limitations Among Adults Aged 45 Years or Older With Versus Without
COPD, By ICML Status, 21 Statesa, 2011 Behavioral Risk Factor Surveillance System
Limitation N
With ICML, PR (95% CI)b
N
Without ICML, PR (95% CI)b
Model 1c Model 2d Model 3e Model 1c Model 2d Model 3e
General limitation
Activity limited for 2 weeks or
more in prior month due to
physical or mental health
8,645 1.85
(1.63–2.10)
1.54
(1.35–1.77)
1.43
(1.26–1.63)
72,695 3.36
(2.96–3.81)
2.16
(1.88–2.49)
1.82
(1.59–2.09)
Health problem required use of
special equipment, such as a
cane,  wheelchair, special bed, or
special telephone
8,798 1.65
(1.42–1.91)
1.34
(1.16–1.57)
1.33
(1.14–1.54)
73,165 2.53
(2.27–2.82)
1.83
(1.64–2.05)
1.74
(1.55–1.95)
Unable to work 8,788 1.92
(1.66–2.21)
1.46
(1.24–1.72)
1.42
(1.20–1.67)
73,071 3.40
(2.92–3.97)
2.10
(1.76–2.50)
1.92
(1.60–2.30)
ICML related limitation
Gave up household chores or
former activities due to ICML
8,589 1.44
(1.25–1.66)
1.19
(1.02–1.38)
1.15
(0.98–1.34)
— — — —
ICML interfered with ability to
work, volunteer, or engage in
social activities
8,577 1.45
(1.27–1.66)
1.22
(1.05–1.41)
1.17
(1.01–1.36)
— — — —
Needed assistance in a domainf 8,446 1.23
(1.14–1.34)
1.11
(1.01–1.21)
1.09
(1.00–1.19)
— — — —
Family or friends provided
assistance in prior 30 days due to
ICML
8,613 1.33
(1.10–1.60)
1.10
(0.89–1.35)
1.06
(0.87–1.30)
— — — —
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICML, increased confusion or memory loss; PR, prevalence ratio; —, not applic-
able.
a Arkansas, California, Florida, Hawaii, Illinois, Iowa, Louisiana, Maryland, Michigan, Nebraska, New Hampshire, New York, North Carolina, Oklahoma, South Caro-
lina, Tennessee, Texas, Utah, Washington, West Virginia, and Wisconsin.
b Comparison is between people with COPD and people without COPD (referent group).
c Adjusted for sex, race, education, state, and age.
d Adjusted for model 1 plus risk behaviors/factors and at least 1 other chronic condition (heart disease, stroke, diabetes, asthma).
e Adjusted for models 1 and 2 plus frequent mental distress (2 weeks or more when mental health was not good).
f Domains are safety, transportation, household activities, personal care, and other.
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